Elythea (YC S23)

👥 4 employees💰 Last funded Feb 2024
>80% of maternal mortalities were preventable with earlier intervention. Currently, doctors miss >50% of moms who have life-threatening complications, and wait until labor to start doing manual risk assessments. Elytheas proprietary ML models catch life-threatening obstetric complications (like postpartum hemorrhage, preeclampsia/eclampsia, emergency c-section, preterm labor, and more) as soon as the first visit. We automatically analyze relevant demographic and clinic risk factors, flag high risk patients, and provide evidence-based interventions to prevent the complication altogether. We have completed prospective international clinical trials across USA, Cameroon, and Nigeria demonstrating that our models have better performance than the current gold standard clinical methods. We have also published studies in AJOG conferences,
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
United States
1
France
1
Frequently asked questions
Who invested in Elythea (YC S23)?
Elythea (YC S23) has 2 investors on record on gritt.io.
When did Elythea (YC S23) last raise funding?
The most recent investment in Elythea (YC S23) recorded on gritt.io was in February 2024.
What industry is Elythea (YC S23) in?
Elythea (YC S23) operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.